Evidence map›Paper›PMID 35454886›Full record

ArticleCancers2022

Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer Status.

Hui-Yi Lin, Tung-Sung Tseng, Xinnan Wang, Zhide Fang, Arnold H Zea, Liang Wang, Julio Pow-Sang, Catherine M Tangen, Phyllis J Goodman, Alicja Wolk and 13 more

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Hui-Yi LinBiostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Tung-Sung TsengBehavioral and Community Health Sciences Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.ORCID 0000-0001-6266-9891
Xinnan WangBiostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Zhide FangBiostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Arnold H ZeaDepartment of Microbiology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Liang WangDepartment of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.ORCID 0000-0002-9364-8572
Julio Pow-SangDepartment of Genitourinary Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Catherine M TangenSWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Phyllis J GoodmanSWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Alicja WolkDepartment of Surgical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden.
Niclas HåkanssonUnit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Manolis KogevinasBarcelona Institute of Global Health (ISGlobal), 08036 Barcelona, Spain.
Javier LlorcaCIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.ORCID 0000-0002-6129-1572
Ben SchöttkerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.ORCID 0000-0002-1217-4521
Jose Esteban CastelaoGenetic Oncology Unit, CHUVI Hospital, Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica Galicia Sur (IISGS), 36204 Vigo, Spain.
Manuela Gago-DominguezGenomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitariode Santiago, Servicio Galego de Saúde, SERGAS, 15706 Santiago de Compostela, Spain.
Marija GamulinDepartment of Oncology, University Hospital Centre Zagreb, 10 000 Zagreb, Croatia.
Davor LesselInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, D-20246 Hamburg, Germany.ORCID 0000-0003-4496-244X
Frank ClaessensMolecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, Campus Gasthuisberg, University of Leuven, Herestraat 49, P.O. Box 901, 3000 Leuven, Belgium.
Steven JoniauDepartment of Urology, University Hospitals Leuven, Herestraat 49, P.O. Box 7003 41, 3000 Leuven, Belgium.ORCID 0000-0003-3195-9890
The Practical ConsortiumThe Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome Consortium, Sutton SM2 5NG, UK.
Jong Y ParkDepartment of Cancer Epidemiology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.ORCID 0000-0002-6384-6447

Funding

SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer ResearchU01CA182883 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TANGEN, CATHERINE M., THOMPSON, IAN M. · 2019 to 2023
$5.4M
NCI NIH HHS U01 CA182883NCI NIH HHS UG1 CA189974
6 · The paper itself

Abstract

backgroundPrevious studies have shown that different alcoholic beverage types impact prostate cancer (PCa) clinical outcomes differently. However, intake patterns of specific alcoholic beverages for PCa status are understudied. The study's objective is to evaluate intake patterns of total alcohol and the three types of beverage (beer, wine, and spirits) by the PCa risk and aggressiveness status.

methodThis is a cross-sectional study using 10,029 men (4676 non-PCa men and 5353 PCa patients) with European ancestry from the PCa consortium. Associations between PCa status and alcohol intake patterns (infrequent, light/moderate, and heavy) were tested using multinomial logistic regressions.

resultsIntake frequency patterns of total alcohol were similar for non-PCa men and PCa patients after adjusting for demographic and other factors. However, PCa patients were more likely to drink wine (light/moderate, OR = 1.11,

conclusionsThe intake patterns of some alcoholic beverage types differed by PCa status. Our findings can provide valuable information for developing custom alcohol interventions for PCa patients.

Indexed as

aggressivenessalcoholbeverageprostate cancer

Identifiers

PMID35454886
PMCPMC9024489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.